Outlook Therapeutics Inc

For the period ended Dec 31, 2023. Filed Feb 14, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2023 · Filed Feb 14, 2024

OTLK$0.44-0.6%Stored close · as of Nov 6, 2026

Opening this filing…